Stockreport

Johnson & Johnson Targets Procedure Growth With Bladder Cancer And Vision Advances [Yahoo! Finance]

Johnson & Johnson  (JNJ) 
Last johnson & johnson earnings: 4/14 06:31 am Check Earnings Report
US:NYSE Investor Relations: jnj.com
PDF Johnson & Johnson (NYSE:JNJ) reported first in human Phase 1 results for an extended release erdafitinib delivery system in non muscle invasive bladder cancer, showing [Read more]